Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
Breast Cancer Now Voices is helping researchers at University College London Hospitals to understand how receiving permanent tattoos to mark the area for radiotherapy treatment affect women.
Researchers based at the Royal College of Surgeons in Ireland have discovered changes in secondary breast cancer that has spread to the brain, which could make the disease vulnerable to drugs called PARP inhibitors.
Tracy recently took part in the SWEET project, which hopes to build a new platform of resources for women undergoing long-term hormone therapy after breast cancer.
We report from the largest breast cancer conference in the world, the San Antonio Breast Cancer Symposium 2021. From cancer blood tests to new drugs, Edd, our Research Communications Officer, shares his highlights.
Researchers at the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London have discovered how cancer cells could resist treatment with PARP inhibitors. It could help make treatment more effective and find who would benefit most from it.
Researchers based at the University of Oxford have discovered a way to boost the effectiveness of a new type of drug which is currently being tested for breast cancer.
It’s been an incredible year of research here at Breast Cancer Now. In this blog, we pick out our favourite research breakthroughs of the year.
How our volunteers are helping to identify the needs and struggles of those supporting men with breast cancer.
The National Cancer Research Institute (NCRI) Festival brings together the brightest scientific and medical minds to advance cancer research in the UK. These are some of this year's highlights.